DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells

Chimeric antigen receptor (CAR) T cell immunotherapies have shown remarkable efficacy in treating multiple types of hematological malignancies but are not sufficiently effective at treating solid tumors. NKG2D is a strong activating receptor for NK cells and a co-stimulatory receptor for T cells. NK...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ruocong Zhao, Lin Cheng, Zhiwu Jiang, Xinru Wei, Baiheng Li, Qiting Wu, Suna Wang, Simiao Lin, Youguo Long, Xuchao Zhang, Yilong Wu, Xin Du, Duanqing Pei, Pentao Liu, Yangqiu Li, Shuzhong Cui, Yao Yao, Peng Li
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2019-01-01
Colecção:OncoImmunology
Assuntos:
car-t
nkg2d
dap10
mesothelin
glypican 3
Acesso em linha:http://dx.doi.org/10.1080/2162402X.2018.1509173
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados